# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001600620-24-000064
Filing Date
2024-05-03
Accepted
2024-05-03 16:08:45
Documents
23
Period of Report
2024-06-14

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | auph-20240502.htm iXBRL | DEF 14A | 1472198
3 |  | auph-20240502_g1.jpg | GRAPHIC | 11010
4 |  | auph-20240502_g10.jpg | GRAPHIC | 184479
5 |  | auph-20240502_g11.jpg | GRAPHIC | 153641
6 |  | auph-20240502_g12.jpg | GRAPHIC | 38273
7 |  | auph-20240502_g2.jpg | GRAPHIC | 49796
8 |  | auph-20240502_g3.jpg | GRAPHIC | 83530
9 |  | auph-20240502_g4.jpg | GRAPHIC | 15830
10 |  | auph-20240502_g5.jpg | GRAPHIC | 13320
11 |  | auph-20240502_g6.jpg | GRAPHIC | 125343
12 |  | auph-20240502_g7.jpg | GRAPHIC | 111152
13 |  | auph-20240502_g8.jpg | GRAPHIC | 109843
14 |  | auph-20240502_g9.jpg | GRAPHIC | 114508
| Complete submission text file | 0001600620-24-000064.txt |  | 4652302

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | auph-20240502.xsd | EX-101.SCH | 934
26 | EXTRACTED XBRL INSTANCE DOCUMENT | auph-20240502_htm.xml | XML | 118698

Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 981231763 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36421 | Film No.: 24913108
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)